Cargando…

Spotlight on early-career researchers: an interview with César de la Fuente

Dr. César de la Fuente is a Presidential Assistant Professor at the University of Pennsylvania. He leads a Machine Biology group developing computational tools to expand the antibiotic arsenal, engineer the microbiome and study and control brain function and behavior. His work has been recognized by...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Q&A
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275088/
https://www.ncbi.nlm.nih.gov/pubmed/32504070
http://dx.doi.org/10.1038/s42003-020-1003-4
_version_ 1783542712639684608
collection PubMed
description Dr. César de la Fuente is a Presidential Assistant Professor at the University of Pennsylvania. He leads a Machine Biology group developing computational tools to expand the antibiotic arsenal, engineer the microbiome and study and control brain function and behavior. His work has been recognized by the Langer Prize, ACS Kavli Emerging Leader in Chemistry award, ACS Infectious Diseases Young Investigator Award, STAT News, GEN, and the MIT Technology Review. We asked Dr. de la Fuente about his research and journey of the field as part of our series on early-career researchers.
format Online
Article
Text
id pubmed-7275088
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72750882020-06-16 Spotlight on early-career researchers: an interview with César de la Fuente Commun Biol Q&A Dr. César de la Fuente is a Presidential Assistant Professor at the University of Pennsylvania. He leads a Machine Biology group developing computational tools to expand the antibiotic arsenal, engineer the microbiome and study and control brain function and behavior. His work has been recognized by the Langer Prize, ACS Kavli Emerging Leader in Chemistry award, ACS Infectious Diseases Young Investigator Award, STAT News, GEN, and the MIT Technology Review. We asked Dr. de la Fuente about his research and journey of the field as part of our series on early-career researchers. Nature Publishing Group UK 2020-06-05 /pmc/articles/PMC7275088/ /pubmed/32504070 http://dx.doi.org/10.1038/s42003-020-1003-4 Text en © Springer Nature Limited 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Q&A
Spotlight on early-career researchers: an interview with César de la Fuente
title Spotlight on early-career researchers: an interview with César de la Fuente
title_full Spotlight on early-career researchers: an interview with César de la Fuente
title_fullStr Spotlight on early-career researchers: an interview with César de la Fuente
title_full_unstemmed Spotlight on early-career researchers: an interview with César de la Fuente
title_short Spotlight on early-career researchers: an interview with César de la Fuente
title_sort spotlight on early-career researchers: an interview with césar de la fuente
topic Q&A
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275088/
https://www.ncbi.nlm.nih.gov/pubmed/32504070
http://dx.doi.org/10.1038/s42003-020-1003-4